Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.57
- Piotroski Score 8.00
- Grade Buy
- Symbol (CLS)
- Company Celestica Inc.
- Price $89.15
- Changes Percentage (-2.5%)
- Change -$2.29
- Day Low $86.44
- Day High $91.73
- Year High $93.15
Celestica Inc. provides hardware platform and supply chain solutions in North America, Europe, and Asia. It operates through two segments, Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, engineering, supply chain management, new product introduction, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services. It also provides enterprise-level data communications and information processing infrastructure products, such as routers, switches, data center interconnects, edge solutions, servers, and storage-related products; capacitors, microprocessors, resistors, and memory modules; and power inverters, energy storage products, smart meters, and other electronic componentry products. The company serves aerospace and defense, industrial, energy, healthtech, capital equipment, original equipment manufacturers, cloud-based, and other service providers, including hyperscalers, and other companies in a range of industries. Celestica Inc. was incorporated in 1994 and is headquartered in Toronto, Canada.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 01/29/2025
- Fiscal Year End N/A
- Average Stock Price Target $65.00
- High Stock Price Target $75.00
- Low Stock Price Target $58.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.68
- Trailing P/E Ratio 19.5
- Forward P/E Ratio 19.5
- P/E Growth 19.5
- Net Income $244.60 M
Income Statement
Quarterly
Annual
Latest News of CLS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ...
The feedback from the AAO meeting on the study design incorporating retreatment with aflibercept was positive. The flexibility was well-received, aligning with physician needs....
By Yahoo! Finance | 1 week ago -
Is CleanSpark, Inc. (CLSK) the Best Cryptocurrency Stock to Buy According to Wall Street?
After Trump's election victory, Bitcoin surged above $80,000, nearing $90,000, as he plans to make America a crypto capital. Trump's support for crypto and potential deregulation could push Bitcoin pr...
By Yahoo! Finance | 1 week ago -
Even after rising 13% this past week, Clearside Biomedical (NASDAQ:CLSD) shareholders are still down 77% over the past three years
Despite Clearside Biomedical, Inc.'s recent 13% share price increase, its three-year returns show a significant decline of 77%. The company's revenue has been shrinking by 38% annually, impacting its ...
By Yahoo! Finance | 1 week ago
